A detailed history of Bank Pictet & Cie (Asia) LTD transactions in Dexcom Inc stock. As of the latest transaction made, Bank Pictet & Cie (Asia) LTD holds 3,171 shares of DXCM stock, worth $230,943. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,171
Previous 3,171 -0.0%
Holding current value
$230,943
Previous $440 Million 18.26%
% of portfolio
0.02%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$114.22 - $140.1 $48,086 - $58,982
-421 Reduced 11.72%
3,171 $440 Million
Q3 2023

Nov 02, 2023

BUY
$86.06 - $137.93 $309,127 - $495,444
3,592 New
3,592 $335 Million
Q4 2018

Jan 31, 2019

SELL
$26.99 - $37.37 $62,077 - $85,951
-2,300 Closed
0 $0
Q2 2018

Aug 09, 2018

BUY
$17.54 - $25.22 $40,342 - $58,006
2,300 New
2,300 $218,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Bank Pictet & Cie (Asia) LTD Portfolio

Follow Bank Pictet & Cie (Asia) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Pictet & Cie (Asia) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Bank Pictet & Cie (Asia) LTD with notifications on news.